| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |